Catalog |
name |
Description |
price |
R-M1-8157 |
DOTA-Yb |
DOTA-Yb is a chelating agent.Dota is a twelve membered tetraazamacrocyclic ligand.Kamulin biology has its own laboratory and technical personnel;professional metal ions, development of macrocyclic ligands and their use as MRI contrast agents; including a series of products such as bifunctional chelating agents, macrocyclic ligands, magnetic resonance reagents, reaction intermediates, etc. |
price> |
R-M1-8158 |
DOTA-Er |
DOTA-Er is a chelating agent.Dota is a twelve membered tetraazamacrocyclic ligand.Kamulin biology has its own laboratory and technical personnel;professional metal ions, development of macrocyclic ligands and their use as MRI contrast agents; including a series of products such as bifunctional chelating agents, macrocyclic ligands, magnetic resonance reagents, reaction intermediates, etc. |
price> |
R-M1-8219 |
NOTA-FAPI-04 |
NOTA-FAPI-04 is a PET Tracer Precursor and and imaging agent.It can be studied by combining radiolabeling with chelates.Radionuclide-labeled fibroblast-activation-protein inhibitor (FAPI), as an important tracer for non-invasive imaging of the tumor microenvironment, can be used to evaluate the expression of FAP in cancer-associated fibroblasts, macrophages, and tumor cells. |
price> |
R-M1-8254 |
4-Aminobutyl-DOTA |
4-Aminobutyl-DOTA is a bifunctional chelating agent. |
price> |
R-M1-8359 |
Gd-DOTA-N3 |
Gd-DOTA-N3,Gadolinium-DOTA-azide from ruixibio.Gd-DOTA has various chemical handles for specific modification of biomolecular sites. Gd-DOTA can be used for the development of new protein targeted MRI contrast agents. |
price> |
R-M1-8365 |
DOTA-DBCO |
DOTA-DBCO can be used as a molecular imaging probe or as a delivery carrier for targeted drugs.Dota is a twelve membered tetraazamacrocyclic ligand. |
price> |
R-M1c-8381 |
DOTA-N-(3-aminopropyl)Methacrylamide |
DOTA-N-(3-aminopropyl)Methacrylamide,1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-N-(3-aminopropyl)Methacrylamide from ruixibio.
DOTA-N-(3-aminopropyl) methylacrylamide, also known as DOTA-AM3, is a bifunctional chelating agent used in the development of radiopharmaceuticals. DOTA stands for 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid, which is a chelating agent that forms stable complexes with various radiometals such as gallium-68, lutetium-177, and others.
The addition of an aminopropyl moiety to the DOTA structure allows for conjugation with targeting molecules such as antibodies, peptides, or small molecules, enabling the development of radiopharmaceuticals for targeted imaging or therapy. By forming stable complexes with radiometals, DOTA-AM3 plays a crucial role in the design and development of radiolabeled compounds for applications in nuclear medicine, including positron emission tomography (PET) imaging and targeted radionuclide therapy.
We can mass produce (kg level),process scaling up, pilot supply,raw material supply, and intermediate production. Our production technology is mature and more cost-effective. Feel free to inquire at any time. |
price> |
R-M1-8608 |
Maleimido-mono-amide-DOTA |
Maleimido-mono-amide-DOTA is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs). |
price> |
R-M1-8734 |
DOTA-Laminarin |
The conjugation of DOTA with laminarin(DOTA-Laminarin/1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Laminarin) allows for chelation of radiometals, such as gallium-68 or lutetium-177, making it suitable for imaging or therapeutic applications. DOTA provides stable coordination of the radiometal, while laminarin acts as a carrier and may potentially offer additional biological activities.The DOTA-Laminarin complex may be utilized in various biomedical fields, including molecular imaging, targeted therapy, and drug delivery systems. By combining the chelating properties of DOTA with the natural polysaccharide laminarin, this complex offers potential applications in molecular imaging or theranostics. |
price> |